Linked Data API
Show Search Form
Search Results
 |
human indexable |  |
 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
published | |
|
||||||||
|
registered interest |  |
|
||||||||
|
answer date |   |
|||||||||
|
date | |
|||||||||
|
date tabled |  |
|||||||||
|
ddp created | |
|||||||||
|
answering body |
|
|||||||||
|
question status | Tabled | |
||||||||
|
answering dept id | 17 | |
||||||||
|
answering dept short name | Health and Social Care | |
||||||||
|
answering dept sort name | Health and Social Care | |
||||||||
|
ddp modified |
|
|||||||||
|
hansard heading | Cystic Fibrosis: Drugs | |
||||||||
|
house id | 1 | |
||||||||
|
identifier | 278928 | |
||||||||
|
legislature |
|
|||||||||
|
parliament number | 57 | |
||||||||
|
question first answered |
|
|||||||||
|
question text | To ask the Secretary of State for Health and Social Care, what recent discussions there have been between Vertex Pharmaceuticals and NHS England with on cystic fibrosis medicines. | |
||||||||
|
session |
|
|||||||||
|
session number | 1 | |
||||||||
|
tabling member constituency | Bristol East |  |
||||||||
|
tabling member printed |
|
|||||||||
|
title | House of Commons Tabled Parliamentary Question 2017/19 278928 | |
||||||||
|
type |
|
|||||||||
|
uin | 278928 | |
||||||||
|
version | 1 | |
||||||||
|
written parliamentary question type | NamedDay | |
||||||||
|
answer |
|
|||||||||
|
creator |
|
|||||||||
|
publisher | 25259 | |||||||||
|
tabling member |
|
|||||||||
